Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q1- Text added to 2021 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
Acceleron, Additionally, ago, alpha, Alzheimer, American, Amgen, backlog, binding, Biocon, bispecific, Century, cetuximab, China, conjugate, converting, decided, deficient, DFA, diligent, directly, dMMR, Eisai, eleven, endometrial, ESA, fluorouracil, folate, Francisco, fulfilled, HCM, hemoglobin, Hikma, histology, infusion, IO, joint, KCCQ, lack, Leiden, malignant, mCRC, mesothelioma, microtubule, minimum, mismatch, Molina, momentum, Mutual, network, neuroscience, NIH, OSS, ovarian, pleural, preclinical, Prothena, QUAZAR, Questionnaire, receipt, repair, Russia, salvage, SCCHN, shipment, specialty, strength, successor, Sweden, tentative, TIGIT, Torrent, trend, trustee, withdrew
Valuein 2021 Q1 filing- Value in 2021 Q2 filing
Original filings
Filing view